Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights Mar 14, 2022 04:05PM
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company Jul 22, 2021 09:15AM
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company Jul 22, 2021 09:15AM
CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination Jul 2, 2021 12:15PM
Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement Jun 10, 2021 05:12PM


May 6, 2021 05:31PM Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger
May 5, 2021 06:10AM CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance
Feb 12, 2021 10:04AM SPAC CM Life Sciences (CMLF) Surges as Cathie Wood's ARK Accumulates New 1.55M Share Stake
Feb 10, 2021 09:30AM Pre-Open Stock Movers 02/10: (TLRY) (GMDA) (CMLF) Higher; (VNRX) (CPST) (XONE) Lower (more...)
Feb 10, 2021 07:02AM Sema4 to Combine with SPAC, CM Life Sciences (CMLF)
Feb 10, 2021 07:00AM  Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth